학술논문
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis
Research / Original Investigation / Caring for the Critically Ill Patient
Research / Original Investigation / Caring for the Critically Ill Patient
Document Type
Report
Author
Sterne, Jonathan A.C.; Murthy, Srinivas; Diaz, Janet V.; Slutsky, Arthur S.; Villar, Jesus; Angus, Derek C.; Annane, Djillali; Pontes Azevedo, Luciano Cesar; Berwanger, Otavio; Cavalcanti, Alexandre B.; Dequin, Pierre-Francois; Du, Bin; Emberson, Jonathan; Fisher, David; Giraudeau, Bruno; Gordon, Anthony C.; Granholm, Anders; Green, Cameron; Haynes, Richard; Heming, Nicholas; Higgins, Julian P.T.; Horby, Peter; Juni, Peter; Landray, Martin J.; Le Gouge, Amelie; Leclerc, Marie; Lim, Wei Shen; Machado, Flavia R.; McArthur, Colin; Meziani, Ferhat; Moller, Morten Hylander; Perner, Anders; Petersen, Marie Warrer; Savovic, Jelena; Tomazini, Bruno; Veiga, Viviane C.; Webb, Steve; Marshall, John C.
Source
JAMA, The Journal of the American Medical Association. Oct 6, 2020, Vol. 324 Issue 13, p1330, 12 p.
Subject
Language
English
ISSN
0098-7484
Abstract
Administration of systemic corticosteroids, compared with usual care or placebo, can be associated with lower 28-day all-cause mortality in critically ill patients with COVID-19. A prospective meta-analysis of 7 randomized trials included 1,703 patients, of whom 647 died. The summary odds ratio between those who received corticosteroids and those who received usual care or placebo was 0.66.